Serum Homocysteine and MTHFR C677T and A1298C gene polymorphisms in Type 2 Diabetic Patients with Nephropathy in Sector of Egyptian Population
Abdelmoaty, M., Bogdady, A., Attia, M. (2013). Serum Homocysteine and MTHFR C677T and A1298C gene polymorphisms in Type 2 Diabetic Patients with Nephropathy in Sector of Egyptian Population. EKB Journal Management System, 33(2), 61-72. doi: 10.21608/besps.2013.35224
Mohamed Abdelmoaty; Ahmed Bogdady; Mervat Attia. "Serum Homocysteine and MTHFR C677T and A1298C gene polymorphisms in Type 2 Diabetic Patients with Nephropathy in Sector of Egyptian Population". EKB Journal Management System, 33, 2, 2013, 61-72. doi: 10.21608/besps.2013.35224
Abdelmoaty, M., Bogdady, A., Attia, M. (2013). 'Serum Homocysteine and MTHFR C677T and A1298C gene polymorphisms in Type 2 Diabetic Patients with Nephropathy in Sector of Egyptian Population', EKB Journal Management System, 33(2), pp. 61-72. doi: 10.21608/besps.2013.35224
Abdelmoaty, M., Bogdady, A., Attia, M. Serum Homocysteine and MTHFR C677T and A1298C gene polymorphisms in Type 2 Diabetic Patients with Nephropathy in Sector of Egyptian Population. EKB Journal Management System, 2013; 33(2): 61-72. doi: 10.21608/besps.2013.35224

Serum Homocysteine and MTHFR C677T and A1298C gene polymorphisms in Type 2 Diabetic Patients with Nephropathy in Sector of Egyptian Population

Bulletin of Egyptian Society for Physiological Sciences
Article 5, Volume 33, Issue 2, December 2013, Page 61-72  XML PDF (389.87 K)
Document Type: Original Article
DOI: 10.21608/besps.2013.35224
View on SCiNiTO View on SCiNiTO
Authors
Mohamed Abdelmoaty* 1; Ahmed Bogdady2; Mervat Attia2
1Department of Medical Biochemistry, Faculty of Medicine, Sohag University
2Department of Internal Medicine Faculty of Medicine, Sohag University
Abstract
Homocysteine (Hcy) is an amino acid, which is a product of methionine demethylation and a precursor to cysteine biosynthesis. Elevations in plasma Hcy (homocysteinemia) are frequently found in increased risk of atherosclerotic, coronary artery disease (CAD), venous thrombosis and stroke. Hcy injuries the endothelium and may have a role in microvascular complication of type 2 diabetes mellitus (T2DM). Two common mutations in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene (MTHFR C677T and A1298C) result in elevated Hcy levels. The aim of the present study was to investigate the relationship between plasma Hcy levels and diabetic nephropathy (DN). Serum Hcy levels, MTHFR genotype, and a panel of
variables were evaluated in a sample of 75 T2DM patients with DN, 55 patients without nephropathy and also 95 non-diabetic control Egyptian subjects. Its common genetic polymorphisms (MTHFR C677T and A1298C) were determined for these patients and control subjects together with their correlation with changes in Hcy levels. Biochemical variables (including 24 hours albuminuria, GFR and serum total Hcy, lipogram and HbA1c beside blood urea and serum creatinine) and lifestyle characteristics were investigated. MTHFR genotype was studied by PCR-RFLP analysis, and total Hcy levels were measured by ELISA. The plasma Hcy levels were significantly higher in the diabetic nephropathy (19.8± 2.3 μmol/L) than uncomplicated type 2 diabetic patients (12.7± 2.1 μmol/L, P<0.05) and also, the control subjects (11.8±1.8μmol/L, P<0.05). There were no differences between uncomplicated diabetic patients and control subjects with respect to Hcy levels. C677T and T677T were highly prevalent among DN patients, with frequencies of 0.40 and 0.36 respectively. C677T, but not A1298C, SNP, is a risk factor for DN, presumably through elevating serum Hcy level.
Keywords
diabetic nephropathy; homocysteine, methylenetetrahydrofolate reductase, type 2diabetes
Statistics
Article View: 125
PDF Download: 224